Bath & Body Works Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Bath & Body Works Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Bath & Body Works, Inc. (NYSE:BBWI) will release earnings results for the third quarter, before the opening bell on Monday, Nov. 25.
Bath & Body Works, Inc.(紐約證券交易所代碼:BBWI)將在11月25日星期一開盤前公佈第三季度業績。
Analysts expect Bath & Body Works to report quarterly earnings at 47 cents per share. That's down from 48 cents per share a year ago. The Columbus, Ohio-based company projects to report quarterly revenue of $1.58 billion, compared to $1.56 billion a year earlier, according to data from Benzinga Pro.
分析師預計,Bath & Body Works公佈的季度收益爲每股47美分。這比去年同期的每股48美分有所下降。根據Benzinga Pro的數據,這家總部位於俄亥俄州哥倫布市的公司預計其季度收入爲15.8億美元,而去年同期爲15.6億美元。
On Nov. 8, Bath & Body Works announced the declaration of its regular quarterly dividend of 20 cents per share payable on Dec. 6, to shareholders of record at the close of business on Nov. 22.
11月8日,Bath & Body Works宣佈其每股20美分的定期季度股息將於12月6日支付給11月22日營業結束時的登記股東。
Bath & Body Works shares gained 0.8% to close at $30.75 on Thursday.
週四,Bath & Body Works股價上漲0.8%,收於30.75美元。
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Benzinga的讀者可以在分析師股票評級頁面上訪問最新的分析師評級。讀者可以按股票行情、公司名稱、分析公司、評級變化或其他變量進行排序。
Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.
讓我們來看看Benzinga最準確的分析師在最近一段時間對該公司的評級。
- Wells Fargo analyst Ike Boruchow maintained an Equal-Weight rating and cut the price target from $35 to $32 on Nov. 6. This analyst has an accuracy rate of 66%.
- BMO Capital analyst Simon Siegel reiterated an Outperform rating and lowered the price target from $52 to $50 on Aug. 29. This analyst has an accuracy rate of 75%.
- Goldman Sachs analyst Kate McShane maintained a Buy rating and cut the price target from $60 to $49 on Aug. 29. This analyst has an accuracy rate of 69%.
- JP Morgan analyst Matthew Boss maintained a Neutral rating and slashed the price target from $42 to $39 on Aug. 29. This analyst has an accuracy rate of 67%.
- Raymond James analyst Olivia Tong maintained a Neutral rating and cut the price target from $51 to $42 on Aug. 29. This analyst has an accuracy rate of 66%.
- 富國銀行分析師艾克·博魯肖維持同等權重評級,並於11月6日將目標股價從35美元下調至32美元。這位分析師的準確率爲66%。
- BMO Capital分析師西蒙·西格爾重申了跑贏大盤的評級,並於8月29日將目標股價從52美元下調至50美元。該分析師的準確率爲75%。
- 高盛分析師凱特·麥克沙恩維持買入評級,並於8月29日將目標股價從60美元下調至49美元。這位分析師的準確率爲69%。
- 摩根大通分析師馬修·博斯維持中性評級,並於8月29日將目標股價從42美元下調至39美元。這位分析師的準確率爲67%。
- 雷蒙德·詹姆斯分析師奧利維亞·湯維持中性評級,並於8月29日將目標股價從51美元下調至42美元。這位分析師的準確率爲66%。
Considering buying BBWI stock? Here's what analysts think:
考慮購買 BBWI 股票?以下是分析師的想法:
![big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20241122/0-0fe34155371f9744e42eee927b99e2a7-0-b3a99c78e993d847bfd624954e0f90bd.png/big)
Read This Next:
接下來閱讀這篇文章:
- Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 5% Dividend Yields
- 華爾街最準確的分析師對3只股息收益率超過5%的醫療保健股票進行了權衡